Pharmaceuticals

Global Cancer Vaccines Market Overview And Prospects

November 23, 2021 by The Business Research Company

Learn about the global cancer vaccines market through The Business Research Company, which provides information on cancer vaccines market size, cancer vaccines market drivers and restraints, cancer vaccines market players, the COVID-19 impact on the cancer vaccines market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global cancer vaccines market is expected to grow from $4.9 billion in 2020 to $5.55 billion in 2021 at a compound annual growth rate (CAGR) of 13.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cancer vaccines market is expected to reach $9.18 billion in 2025 at a CAGR of 13%.

The rise in the number of cancer cases across the globe is expected to drive innovation in cancer vaccines manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global Cancer Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smph

The cancer vaccines market consists of sales of vaccines used for the treatment of cancers and related services by entities (organizations, sole traders and partnerships) that produce vaccines for cancer treatment. Cancer treatment vaccines, also called therapeutic vaccines are a type of immunotherapy, which stops tumor growth, destroys cancer cells and prevents the reoccurrence of cancers. The market consists of revenue generated by the company’s manufacturing cancer vaccines by the sales of these products.

Global cancer vaccines market segments include:

By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

By Cancer Type: Prostate, Cervical, Colorectal, Throat, Others

By End-User: Cancer Treatment Centres, Research Institutes

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Companies in the cancer vaccines market are increasingly investing in preventive or prophylactic vaccines for cancer prevention. Prophylactic vaccines are designed to build immunity in a patient. A prophylactic or preventative vaccine involves introducing antigens into a person’s body.

TBRC’s cancer vaccines market report covers:

Major Market Players: GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi Pasteur, Sanpower Group, and CSL Limited.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Cancer Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides cancer vaccines market overviews, analyzes and forecasts market size, share, cancer vaccines market players, cancer vaccines market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s cancer vaccines market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Vaccines Global Market Report 2021

Pediatric Vaccine Global Market Report 2021

DTP Vaccines Global Market Report 2021

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model